Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Eur J Gastroenterol Hepatol. 2012 Jan;24(1):64–69. doi: 10.1097/MEG.0b013e32834d09f1

Table 2.

Participant Demographic, Adherence, and Disease Characteristics

Adolescent age (years) 15.4 ± 1.5
Gender (% male) 50%
Ethnicity (% White, not Hispanic origin) 90%
Primary Caregiver:
    Age (years) 46.2 ± 4.9
    Marital Status (% married) 87.5%
    Education Level (% with at least a college degree) 45%
Annual Household Income (Median) $100,001-125,000
IBD Diagnosis (%):
    Crohn's Disease 75.0%
    Ulcerative Colitis 17.5%
    Indeterminate Colitis 7.5%
Disease Severity: Baseline Post-treatment
    PHBI 2.10 ± 2.27 2.87 ± 2.66
    PUCAI 14.0 ± 15.06 12.0 ± 14.18
Adherence:
        Pill Count - 6-MP/azathioprine 66% 56%
        Pill Count - mesalamine 51% 50%
        Electronic monitor 89% 84%
        Parent-reported - 6-MP/azathioprine 83% 81%
        Parent-reported - mesalamine 89% 94%
        Teen-reported - 6-MP/azathioprine 87% 87%
        Teen-reported - mesalamine 93% 96%